idenix pharmaceuticals inc
(IDIX:NASDAQ GS)
Executive Profile*
David N. Standring Ph.D.Chief Scientific Officer and Executive Vice President, Idenix Pharmaceuticals Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 1 different industries. |
| 61 | $1,401,683 As of Fiscal Year 2012 |
Background*
Dr. David N. Standring, Ph.D., has been Chief Scientific Officer and Executive Vice President of Idenix Pharmaceuticals Inc. since February 2011. Dr. Standring served as Executive Vice President, Biology of Idenix Pharmaceuticals Inc. from December 2007 to February 2011. Dr. Standring served as Vice President of Biology of Idenix Pharmaceuticals Inc. from March 2002 to March 2006 and as its Senior Vice President of Biology from March 2006 to December 2007. He served ...
Corporate Headquarters*60 Hampshire StreetCambridge, Massachusetts 02139 United States Phone: 617-995-9800 Fax: 617-995-9801 Board Members Memberships*There is no Board Members Memberships data available.Education*PhD Harvard University BA St John's College, Oxford University
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| IDIX:US | $4.31 USD | +0.12 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Lamberto Andreotti | Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee Bristol-Myers Squibb Company | $1.6M |
| Jeffrey M. Leiden M.D., Ph.D. | Chairman, Chief Executive Officer and President Vertex Pharmaceuticals Incorporated | $1.0M |
| Andrew Philip Witty | Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee GlaxoSmithKline plc | 1.9M GBP | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact IDENIX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








